Narrow search
Showing 1 - 10 of 14,268
Cover Image
Drug Development - Stuck in a State of Puberty? : Regulatory Reform of Human Clinical Research to Raise Responsiveness to the Reality of Human Variability
Malinowski, Michael J. - 2012
about the sufficiency of FDA *364 regulation. This Article questions how prescription medicines reach the market and …
Persistent link: https://www.econbiz.de/10013098116
Cover Image
Do cost-sharing and entry deregulation curb pharmaceutical innovation?
Grossmann, Volker - In: Journal of health economics 32 (2013) 5, pp. 881-894
Persistent link: https://www.econbiz.de/10010210741
Cover Image
Improving regulation for innovation : evidence from China's pharmaceutical industry
Jia, Ruixue; Ma, Xiao; Yang, Jianan; Zhang, Yiran - 2023
Persistent link: https://www.econbiz.de/10014443086
Cover Image
Innovation, régulation des prix et politique du médicament
Bureau, Dominique; Scherrer, Sylvie - In: Revue d'économie politique 110 (2000) 4, pp. 513-539
Persistent link: https://www.econbiz.de/10001512648
Cover Image
Reforming the Swedish pharmaceuticals market : consequences for costs per defined daily dose
Bergman, Mats A.; Granlund, David; Rudholm, Niklas - In: International journal of health economics and management 16 (2016) 3, pp. 201-214
Persistent link: https://www.econbiz.de/10011811445
Cover Image
A locational analysis of deregulation policies in the Spanish retail pharmaceutical sector
Bruno, Giuseppe; Cavola, Manuel; Diglio, Antonio; … - In: Socio-economic planning sciences : the international … 82 (2022) 1, pp. 1-11
Persistent link: https://www.econbiz.de/10013363520
Cover Image
Opening the OTC drug market : the effect of deregulation on retail pharmacy's performance
Jo, Wooyong; Nam, Hyoryung; Choi, Jeonghye - In: International journal of research in marketing : IJRM ; … 39 (2022) 3, pp. 847-866
Persistent link: https://www.econbiz.de/10013399635
Cover Image
Die Funktionen der unabhängigen Apotheke für die Arzneimittelversorgung der GKV und das Fremd- und Mehrbesitzverbot
Burk, Enno - 2008 - 1. Aufl.
Persistent link: https://www.econbiz.de/10003720766
Cover Image
Do Cost-Sharing and Entry Deregulation Curb Pharmaceutical Innovation?
Grossmann, Volker - 2011
This paper examines the role of both cost-sharing schemes in health insurance systems and entry regulation for … deregulation may lead to quality-improvements of pharmaceuticals, despite reducing price-setting power of pharmaceutical companies …
Persistent link: https://www.econbiz.de/10013125326